Evaluation of the fusion partner cell line SPYMEG for obtaining human monoclonal antibodies against influenza B virus

Influenza B virus has been known to infect humans and other animals, including seals. Vaccination efficacy varies across seasons. Human monoclonal antibodies (mAbs) can be useful for developing novel vaccines, guided by epitope analysis, and can be used therapeutically. Hybridoma technology has been...

Descripción completa

Detalles Bibliográficos
Autores principales: SONI, Priyanka, YASUHARA, Atsuhiro, TAKENAGA, Toru, IWATSUKI-HORIMOTO, Kiyoko, URAKI, Ryuta, ITO, Mutsumi, SASAKI, Tadahiro, IKUTA, Kazuyoshi, YAMAYOSHI, Seiya, KAWAOKA, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Veterinary Science 2018
Materias:
Virology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021880/
https://www.ncbi.nlm.nih.gov/pubmed/29669959
http://dx.doi.org/10.1292/jvms.18-0146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021880/
https://www.ncbi.nlm.nih.gov/pubmed/29669959
http://dx.doi.org/10.1292/jvms.18-0146

Ejemplares similares